Braskem S.A. (BAK) vs MOLECULAR DATA (MKD)

Braskem S.A. and MOLECULAR DATA are both Chemicals companies. Braskem S.A. is the larger, with a market value of $272.2M against $74.9M — 3.6× the size. MOLECULAR DATA has the higher net margin (−2.29% vs −17.2%) and the higher return on invested capital (0.00% vs −2,286.9%). Across the 14 metrics below, MOLECULAR DATA leads on 11 and Braskem S.A. on 3.

Valuation

Metric BAK MKD Chemicals median
P/E n/m n/m —
P/S 0.07 n/m 0.44
P/B n/m n/m 1.13
Price to free cash flow n/m n/m 7.30
EV/EBITDA 7.52 n/m 9.48
EV/Sales 0.07 (0.03) 0.86
Earnings yield (157.79%) 0.00% (10.53%)
Free cash flow yield (98.70%) 0.00% 4.86%

Profitability

Metric BAK MKD Chemicals median
Gross margin 2.19% 33.02% 16.03%
Operating margin (3.57%) 0.00% (0.82%)
Net margin (17.15%) (2.29%) (3.05%)
Free cash flow margin (6.74%) (3.62%) 1.50%
Return on equity 542.49% 0.00% (5.24%)
Return on assets (19.43%) 0.00% (2.51%)
Return on invested capital (2,286.92%) 0.00% (0.75%)

Growth

Metric BAK MKD Chemicals median
Revenue growth (TTM) (32.61%) — 2.53%
EPS growth (last fiscal year) 15.75% (45.25%) —
Revenue growth, 5-year CAGR 2.20% — 2.20%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BAK MKD Chemicals median
Debt to equity (4.91) 1.15 0.71
Current ratio 0.77 1.10 1.99
Net debt to EBITDA 19.18 0.84 3.49

Dividend

Metric BAK MKD Chemicals median
Dividend yield 0.37% — 2.33%
Payout ratio 0.00 0.00 0.00

Size

Metric BAK MKD Chemicals median
Market cap 272.24m 74.92m 643.59m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack